Health Care Technology(BK4167),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4167 Health Care Technology

Closed 01-22 16:00:00 EST

3,239.28

+71.16

+2.25%

High3,258.44	Low3,168.25	Vol298.38M
Open3,168.25	D1 Closing3,168.12	Amplitude2.85%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O805.07M	T/O Rate--	Tradable Shares0.00
P/B3.401446	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4167","market":"US","secType":"PLATE","nameCN":"Health Care Technology","latestPrice":3239.2754,"timestamp":1769115599999,"preClose":3168.1194,"halted":0,"volume":298382594,"delay":0,"changeRate":0.02246,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":71.156006,"latestTime":"01-22 16:00:00 EST","open":3168.2456,"high":3258.442,"low":3168.2456,"amount":805065249.398808,"amplitude":0.02847,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1769130000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.401446,"peRate":-157.468231,"turnoverRate":0.203231,"increases":25,"decrements":8,"flats":0,"marketCap":63021406930.75,"floatMarketCap":50975518783},"requestUrl":"/m/hq/s/BK4167/wiki","defaultTab":"wiki","newsList":[{"id":"2605341108","title":"Truist downgrades Inspire Medical as coding uncertainty takes upside off table","url":"https://stock-news.laohu8.com/highlight/detail?id=2605341108","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605341108?lang=en_us&edition=fundamental","pubTime":"2026-01-23 03:15","pubTimestamp":1769109323,"startTime":"0","endTime":"0","summary":"As previously reported, Truist downgraded Inspire Medical (INSP) to Hold from Buy with a price target of $96, down from $120, given the CMS and MAC...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/truist-downgrades-inspire-medical-as-coding-uncertainty-takes-upside-off-table-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/truist-downgrades-inspire-medical-as-coding-uncertainty-takes-upside-off-table-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INSP","LU2065731478.USD","BK4167","BK4082"],"gpt_icon":0},{"id":"2605141170","title":"Inspire Medical downgraded to Hold from Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2605141170","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605141170?lang=en_us&edition=fundamental","pubTime":"2026-01-23 03:10","pubTimestamp":1769109015,"startTime":"0","endTime":"0","summary":"Truist analyst Richard Newitter downgraded Inspire Medical (INSP) to Hold from Buy with a $96 price target Published first on TheFly – the ultimate...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inspire-medical-downgraded-to-hold-from-buy-at-truist-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inspire-medical-downgraded-to-hold-from-buy-at-truist-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INSP","LU2065731478.USD","BK4082","BK4167"],"gpt_icon":0},{"id":"2605419190","title":"Analysts Are Bullish on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Inspire Medical Systems (INSP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605419190","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605419190?lang=en_us&edition=fundamental","pubTime":"2026-01-23 02:10","pubTimestamp":1769105435,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pacira Pharmaceuticals (PCRX – Research Report), Ins...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-pacira-pharmaceuticals-pcrx-inspire-medical-systems-insp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-pacira-pharmaceuticals-pcrx-inspire-medical-systems-insp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4167","BK4585","BK4082","INSP","LABU","LU2065731478.USD","PCRX","LU0029874061.USD","BK4007","BK4137","BK4581","BK4588","XBI","BK4112"],"gpt_icon":0},{"id":"2605490113","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Simulations Plus (SLP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2605490113","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605490113?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:50","pubTimestamp":1769093419,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Abbott Laboratories (ABT – Research Report) and Simu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-simulations-plus-slp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-and-simulations-plus-slp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","LU0868494617.USD","BK4585","BK4167","LU0122379950.USD","LABU","LU1989763427.SGD","LU2211815571.USD","SGXZ23171101.USD","SG9999002232.USD","LU2112291526.USD","LU0234572021.USD","LU2089984988.USD","LU1061106388.HKD","LU2324357040.USD","LU0128526141.USD","LU1721429402.USD","LU2237957811.SGD","LU0058720904.USD","LU2133065610.SGD","IE0009355771.USD","LU1023059063.AUD","SG9999002224.SGD","IE00BJJMRZ35.SGD","SG9999004303.SGD","LU1691799644.USD","BK4592","LU2237957902.USD","XBI","HCSG","BK4137","LU0170899867.USD","BK4566","IE0002141913.USD","SGXZ41872573.SGD","LU0882574055.USD","BK4533","LU1914381329.SGD","BK4504","LU1989763690.USD","IE00BFTCPJ56.SGD","ABT","LU0266013472.USD","LU1721429741.USD","SLP","BK4581","IE00B4R5TH58.HKD","XLV","BK4082","LU2468319806.SGD"],"gpt_icon":0},{"id":"2605349278","title":"OneMedNet announces data supported FDA 510k clearance of Scaida BrainCT-ICH","url":"https://stock-news.laohu8.com/highlight/detail?id=2605349278","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605349278?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:11","pubTimestamp":1769091076,"startTime":"0","endTime":"0","summary":"OneMedNet (ONMD) announced that its clinical data supported mlHealth 360 in obtaining U.S. Food and Drug Administration, FDA, 510(k) clearance for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/onemednet-announces-data-supported-fda-510k-clearance-of-scaida-brainct-ich-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/onemednet-announces-data-supported-fda-510k-clearance-of-scaida-brainct-ich-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","ONMD"],"gpt_icon":0},{"id":"2605494794","title":"Onemednet Real-World Data Supports FDA 510(K) Clearance of AI-Powered Scaida Brainct-Ich Software","url":"https://stock-news.laohu8.com/highlight/detail?id=2605494794","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605494794?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:00","pubTimestamp":1769090403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUA97GQLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","ONMD"],"gpt_icon":0},{"id":"2605491770","title":"Doximity Inc : Jefferies Cuts Target Price to $67 From $83","url":"https://stock-news.laohu8.com/highlight/detail?id=2605491770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605491770?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:33","pubTimestamp":1769088838,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nFWN3YN15M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DOCS","BK4167","BK4539","BK4551","BK4588","BK4613","BK4585"],"gpt_icon":0},{"id":"2605849114","title":"GoodRx Holdings Cut to Hold From Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605849114","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605849114?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:22","pubTimestamp":1769088120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GDRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 22, 2026 08:22 ET (13:22 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDRX","BK4167"],"gpt_icon":0},{"id":"2605499748","title":"Healthcare Triangle, Inc. Signs Definitive Agreement With Teyame AI Llc Which Is Forecasted to Generate $38M in Incremental Ntm Revenue and Incremental Ntm Ebitda of $5M in Addition to Expanding Its Saas Footprint in Europe and Latin America","url":"https://stock-news.laohu8.com/highlight/detail?id=2605499748","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605499748?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:10","pubTimestamp":1769087400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUA5XGVDN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HCTI","BK4167"],"gpt_icon":0},{"id":"2605499043","title":"Healthcare Triangle Inc - Deal Contemplates up to $50 Mln in Total Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2605499043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605499043?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:10","pubTimestamp":1769087400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUA5XGVDN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","HCTI"],"gpt_icon":0},{"id":"2605499283","title":"CareCloud’s Wellsoft Ranked #1 EHR by Black Book 2026 for Emergency Medicine","url":"https://stock-news.laohu8.com/highlight/detail?id=2605499283","media":"GlobeNewswire","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605499283?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:00","pubTimestamp":1769086800,"startTime":"0","endTime":"0","summary":"SOMERSET, N.J., Jan.  22, 2026  (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/22/3223677/16541/en/CareCloud-s-Wellsoft-Ranked-1-EHR-by-Black-Book-2026-for-Emergency-Medicine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0661504455.SGD","SG9999011175.SGD","LU0690374961.EUR","LU1506573853.SGD","LU1066051811.HKD","LU0949170772.SGD","LU0690374615.EUR","LU1043141123.HKD","SG9999001440.SGD","LU0738911758.USD","LU1116320901.HKD","CCLD","LU1116320737.USD","LU1228905037.USD","LU0265550946.USD","LU1228905540.USD","BK4167","GB00B4QBRK32.GBP","BK4075","HK0000914660.USD","BK4588","LU0545562505.USD","LU0426412945.USD","LU2404859741.USD","SG9999003800.SGD","LU1066053197.SGD","LU0314106906.USD","LU0994945656.USD","PM","LU0265550359.USD","LU1043141396.HKD","BK4585","LU1066051498.USD","LU1914381329.SGD","BK4566","LU1066051225.USD","LU2404859667.USD","IE000M9KFDE8.USD","LU2381873111.SGD","HK0000914686.HKD","LU1121112475.USD","GB00B4LPDJ14.GBP","LU0426417589.USD"],"gpt_icon":0},{"id":"2605675034","title":"GoodRx downgraded to Hold from Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605675034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605675034?lang=en_us&edition=fundamental","pubTime":"2026-01-22 18:15","pubTimestamp":1769076959,"startTime":"0","endTime":"0","summary":"Jefferies downgraded GoodRx (GDRX) to Hold from Buy with a price target of $2.75, down from $5.25. The company’s prescription discount segment, whi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/goodrx-downgraded-to-hold-from-buy-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/goodrx-downgraded-to-hold-from-buy-at-jefferies-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","GDRX"],"gpt_icon":0},{"id":"2605170435","title":"TruBridge Inc. Files Initial Statement of Beneficial Ownership by Director Damien Leonard","url":"https://stock-news.laohu8.com/highlight/detail?id=2605170435","media":"Reuters","labels":["executive","shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605170435?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:50","pubTimestamp":1769032245,"startTime":"0","endTime":"0","summary":"TruBridge Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Damien Leonard as a director and the beneficial owner of shares held indirectly through L6 Holdings Inc. and Pinetree Capital Ltd. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trubridge Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 21, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL4rxf5J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"TruBridge Inc. Files Initial Statement of Beneficial Ownership by Director Damien Leonard","news_tag":"executive,shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","TBRG"],"gpt_icon":0},{"id":"2605438773","title":"Simulations Plus Unveils AI-Enabled Drug Development Platform at 2026 Investor Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2605438773","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605438773?lang=en_us&edition=fundamental","pubTime":"2026-01-22 05:06","pubTimestamp":1769029606,"startTime":"0","endTime":"0","summary":"Simulations Plus Inc., a global leader in model-informed and AI-accelerated drug development, recently hosted its 2026 Virtual Investor Day. During the event, the company highlighted its strategic direction and platform innovations, focusing on the evolution from a collection of best-in-class tools to an integrated, AI-enabled ecosystem supporting drug discovery, development, clinical operations, and commercialization. Company leaders emphasized the integration of cloud-enabled execution, reusable workflow patterns, and AI-assisted capabilities aimed at improving productivity and ensuring regulator-ready documentation. The event also underscored Simulations Plus’s commitment to aligning with FDA and EMA guidelines by using AI to augment, not replace, mechanistic modeling, ensuring outputs remain explainable and scientifically validated. A replay of the Investor Day broadcast is available on the Simulations Plus website.Disclaimer: This news brief was created by Public Technologies  usi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL2tjlyl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SLP"],"gpt_icon":0},{"id":"2605481110","title":"Teladoc call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2605481110","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605481110?lang=en_us&edition=fundamental","pubTime":"2026-01-22 00:45","pubTimestamp":1769013915,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in Teladoc (TDOC) with 33,095 calls trading, 7x expected, and implied vol increasing almost 2 points to 62.14%. 1/30 w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teladoc-call-volume-above-normal-and-directionally-bullish-thefly-12?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teladoc-call-volume-above-normal-and-directionally-bullish-thefly-12?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4567","BK4548","TDOC","BK4167","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4504","BK4588","BK4534"],"gpt_icon":0},{"id":"2605481838","title":"YCANTH Phase 3 Wart Study Puts Verrica in Focus While Veeva Extends Its Clinical Footprint","url":"https://stock-news.laohu8.com/highlight/detail?id=2605481838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605481838?lang=en_us&edition=fundamental","pubTime":"2026-01-22 00:36","pubTimestamp":1769013391,"startTime":"0","endTime":"0","summary":"Veeva Systems Inc ($VEEV), Verrica Pharmaceuticals ($VRCA) announced an update on their ongoing clinical study. Study OverviewCOVE-2 is a Phase 3 c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ycanth-phase-3-wart-study-puts-verrica-in-focus-while-veeva-extends-its-clinical-footprint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ycanth-phase-3-wart-study-puts-verrica-in-focus-while-veeva-extends-its-clinical-footprint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU0266013472.USD","LU0289739699.SGD","LU1989764748.USD","BK4167","LU0170899867.USD","BK4528","VEEV","BK4588","BK4534","LU1989764664.SGD","BK4585","BK4613","BK4504"],"gpt_icon":0},{"id":"2605071781","title":"Claritev enters strategic relationship with Kinetiq Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2605071781","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605071781?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:17","pubTimestamp":1769001425,"startTime":"0","endTime":"0","summary":"Claritev (CTEV) announced a strategic relationship with Kinetiq Health. The combined offering delivers monthly medical and pharmacy claims surveill...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/claritev-enters-strategic-relationship-with-kinetiq-health-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/claritev-enters-strategic-relationship-with-kinetiq-health-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CTEV","BK4167"],"gpt_icon":0},{"id":"2605310220","title":"DarioHealth Surpasses 100 Peer-Reviewed Studies Demonstrating Digital Health Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2605310220","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605310220?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:02","pubTimestamp":1769000524,"startTime":"0","endTime":"0","summary":"DarioHealth Corp. has announced it has surpassed 100 scientific studies, including peer-reviewed journal publications and peer-reviewed conference abstracts, reinforcing its leadership in evidence-based digital health. The company highlighted that these results have already been presented in respected venues such as the Journal of Medical Internet Research and major conferences. DarioHealth’s research portfolio includes large, real-world study populations, longitudinal designs of up to two years, independent third-party validations, and directly observed outcomes like claims reduction and improved HbA1c levels. This milestone places DarioHealth among the top digital health vendors for scientific rigor and measurable impact, distinguishing it as a trusted partner for employers and health plans seeking validated solutions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL3FYgWb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","DRIO","BK4167"],"gpt_icon":0},{"id":"2605449102","title":"Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty","url":"https://stock-news.laohu8.com/highlight/detail?id=2605449102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605449102?lang=en_us&edition=fundamental","pubTime":"2026-01-21 21:00","pubTimestamp":1769000423,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nFWN3YM0PZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","CTEV"],"gpt_icon":0},{"id":"2605101738","title":"Claritev Corporation Partners with Kinetiq Health to Enhance Healthcare Cost Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2605101738","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605101738?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:15","pubTimestamp":1768997743,"startTime":"0","endTime":"0","summary":"Claritev Corporation has announced a strategic partnership with Kinetiq Health to enhance cost management and advance claims surveillance and diagnostic certainty in healthcare. The collaboration will integrate Kinetiq Health's risk management services with Claritev's BenInsights analytics platform, aiming to help employers, brokers, TPAs, and health plans identify high-cost medical and pharmacy risks earlier, improve diagnostic accuracy, and achieve better financial outcomes. The partnership is designed to deliver value through earlier risk identification, greater diagnostic confidence, and improved cost management for organizations across the healthcare sector.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Claritev Corporation publi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDL56nNJc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","CTEV"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":0.0008},{"period":"3month","weight":0.0203},{"period":"6month","weight":0.0758},{"period":"1year","weight":0.1366},{"period":"ytd","weight":0.0051}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4167","nameEN":"BK4167"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Health Care Technology(BK4167),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Health Care Technology(BK4167) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Health Care Technology,BK4167,Health Care Technology股票,Health Care Technology股票老虎,Health Care Technology股票老虎国际,Health Care Technology行情,Health Care Technology股票行情,Health Care Technology股价,Health Care Technology股市,Health Care Technology股票价格,Health Care Technology股票交易,Health Care Technology股票购买,Health Care Technology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Health Care Technology(BK4167),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Health Care Technology(BK4167) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}